Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43

Polymenidou, Magdalini, Lagier-Tourenne, Clotilde, Hutt, Kasey R, Huelga, Stephanie C, Moran, Jacqueline, Liang, Tiffany Y, Ling, Shuo-Chien, Sun, Eveline +9 more·2011·Nature Neuroscience
DOI 10.1038/nn.2779

Cited by (1,001)

Items 801–900 of 1,001

  1. Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPSNs
    Jeffrey D. Rothstein, Caroline Warlick, Alyssa N. Coyne · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding
    Francesca Simonetti, Weijia Zhong, Saskia Hutten, Federico Uliana, Martina Schifferer, Ali Rezaei, Lisa Marie Ramirez, Janine Hochmair, Rithika Sankar, Anusha B. Gopalan et al. · 2025 · The EMBO Journal
  3. Hitting the mark: Localization of mRNA and biomolecular condensates in health and disease
    Jessica P. Otis, Kimberly L. Mowry · 2023 · Wiley Interdisciplinary Reviews - RNA
  4. Understanding age-related pathologic changes in TDP-43 functions and the consequence on RNA splicing and signalling in health and disease
    Flora Cheng, Tyler R. Chapman, Selina Zhang, Marco Morsch, Roger S. Chung, Albert Lee, Stephanie L. Rayner · 2024 · Ageing Research Reviews
  5. pTDP-43 levels correlate with cell type–specific molecular alterations in the prefrontal cortex of C9orf72 ALS/FTD patients
    Hsiao‐Lin V. Wang, Jian‐Feng Xiang, Chenyang Yuan, Austin M. Veire, Tania F. Gendron, Melissa Erin Murray, Malú G. Tansey, Jian Hu, Marla Gearing, Jonathan D. Glass et al. · 2025 · Proceedings of the National Academy of Sciences
  6. Leucine‐rich repeat kinase 2 and alternative splicing in Parkinson's disease
    David A. Elliott, Woojin Scott Kim, Sarsha Gorissen, Glenda Margaret Halliday, John B. Kwok · 2012 · Movement Disorders
  7. Augmented quantal release of acetylcholine at the vertebrate neuromuscular junction following tdp-43 depletion
    Stefania Dzieciolowska, Pierre Drapeau, Gary A.B. Armstrong · 2017 · PLoS ONE
  8. The Caenorhabditis elegans Ortholog of TDP-43 Regulates the Chromatin Localization of the Heterochromatin Protein 1 Homolog HPL-2
    Tassa K. Saldi, Patrick K. Gonzales, Alfonso Garrido‐Lecca, Vishantie Dostal, Christine M. Roberts, Leonard Petrucelli, Christopher D. Link · 2018 · Molecular and Cellular Biology
  9. Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction
    Mathieu Bartoletti, Daryl A. Bosco, Sandrine Da Cruz, Clotilde Lagier‐Tourenne, Nicole F. Liachko, Sebastian Markmiller, Kristin M. Webster, Kristi A. Wharton · 2019 · Journal of Neuroscience
  10. Promise of Nucleic Acid Therapeutics for Amyotrophic Lateral Sclerosis
    Daisuke Ito · 2021 · Annals of Neurology
  11. Effect of TDP43-CTFs35 on Brain Endothelial Cell Functions in Cerebral Ischemic Injury
    Xiaotian Xu, Changwen Zhang, Jianxiong Jiang, Mei Xin, Jiukuan Hao · 2022 · Molecular Neurobiology
  12. Motor Neuron Diseases
    Philip C. Wong, Po‐Min Chiang, Lee J. Martin, Vassilis E. Koliatsos, Donald L. Price · 2012 · Elsevier eBooks
  13. Soluble sortilin is present in excess and positively correlates with progranulin in CSF of aging individuals
    Simon Mølgaard, Ditte Demontis, Alexandra M. Nicholson, NiCole A. Finch, Ronald Carl Petersen, Claus Munck Petersen, Rosa Rademakers, Anders Nykjær, Simon Glerup · 2016 · Experimental Gerontology
  14. Quantitative analysis of cryptic splicing associated with TDP-43 depletion
    Jack Humphrey, Warren Emmett, Pietro Fratta, Adrian M. Isaacs, Vincent Plagnol · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  15. The mechanisms underlying TDP-43-associated neurodegeneration in Alzheimer’s disease and related dementias
    Ju Gao, Mao Ding, Siyue Qin, Devanshi Shukla, Lauren Vicuna, Jingjing Liang, Xinglong Wang · 2025 · Molecular Psychiatry
  16. Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels
    Nikolina Prtenjača, Matea Rob, Muhammad Shamsul Alam, Andrea Markovinović, Cristiana Stuani, Emanuele Buratti, Ivana Munitić · 2022 · International Journal of Molecular Sciences
  17. C9orf72 poly(PR) aggregation in nucleus induces ALS/FTD-related neurodegeneration in cynomolgus monkeys
    Lizhu Xu, Dan Wang, Lu Zhao, Zhengsheng Yang, Xu Liu, Xinyue Li, Tingli Yuan, Ye Wang, Tianzhuang Huang, Ning Bian et al. · 2023 · Neurobiology of Disease
  18. Proteomics elucidating physiological and pathological functions of TDP‐43
    Jorge García Morato, Christian Johannes Gloeckner, Philipp J. Kahle · 2023 · PROTEOMICS
  19. TDP-43 Epigenetic Facets and Their Neurodegenerative Implications
    Juliette Gimenez, Alida Spalloni, Sara Cappelli, Francesca Ciaiola, Valerio Orlando, Emanuele Buratti, Patrizia Longone · 2023 · International Journal of Molecular Sciences
  20. Exploring Endoplasmic Reticulum Dysfunction on Protein Phase Separation Using Viscosity-Sensitive Fluorescent Lifetime Probe
    Yu Wei, Xiangyu Zi, Jia Zhai, Man Zhang, Jiaqi Li, Zhenglong Sun, Minzi Ju, Xin Zhang, Baoxing Shen · 2025 · Analytical Chemistry
  21. Transcription and Splicing Factor TDP-43: Role in Regulation of Gene Expression in Testis
    Prabhakara Poothi Reddi · 2017 · Seminars in Reproductive Medicine
  22. mRNA isoform balance in neuronal development and disease
    Geneva R. LaForce, Polyxeni Philippidou, Ashleigh E. Schaffer · 2022 · Wiley Interdisciplinary Reviews - RNA
  23. TDP-43 Identified from a Genome Wide RNAi Screen for SOD1 Regulators
    Balajee R. Somalinga, Cameron E. Day, Shuguang Wei, Michael G. Roth, Philip Thomas · 2012 · PLoS ONE
  24. Aberrant Rna Homeostasis in Amyotrophic Lateral Sclerosis: Potential for New Therapeutic targets?
    Christopher J. Donnelly, Jonathan C. Grima, Rita Sattler · 2014 · Neurodegenerative Disease Management
  25. A genomic view on epilepsy and autism candidate genes
    Kamel Jabbari, Peter Nürnberg · 2016 · Genomics
  26. TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS/FTD and related disorders
    Frederick J. Arnold, Ya Cui, Sebastian Michels, Michael R. Colwin, Cameron M. Stockford, Wenbin Ye, Oliver H. Tam, Sneha Menon, Wendy G. Situ, Kean C. K. Ehsani et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  27. RNA-Binding Proteins as Epigenetic Regulators of Brain Functions and Their Involvement in Neurodegeneration
    Carlo Maria Di Liegro, Gabriella Schiera, Giuseppe Schirò, Italia Di Liegro · 2022 · International Journal of Molecular Sciences
  28. Tandem Detergent-Extraction and Immunoprecipitation of Proteinopathy (TDiP): Scalable Enrichment of ALS-Associated TDP-43 Aggregates
    Baggio Evangelista, Shannon R. Cahalan, Joey V. Ragusa, Angie L. Mordant, Julie Necarsulmer, Robert J. Perna, Tejazaditya Ajit, Kristen White, Natalie K. Barker, Xu Tian et al. · 2022 · iScience
  29. Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington’s disease knock-in mice
    Dazhang Bai, Longhong Zhu, Qingqing Jia, Xuezhi Duan, Laiqiang Chen, Xiang Wang, Junqi Hou, Guohui Jiang, Su Yang, Shihua Li et al. · 2023 · Progress in Neurobiology
  30. RNA and the RNA-binding protein FUS act in concert to prevent TDP-43 spatial segregation
    Clément Demongin, S. Tranier, Vandana Joshi, Léa Ceschi, Bénédicte Desforges, David Pastré, Loïc Hamon · 2024 · Journal of Biological Chemistry
  31. Microtubules, Membranes, and Movement: New Roles for Stathmin‐2 in Axon Integrity
    Emma J. C. Thornburg‐Suresh, Daniel W. Summers · 2024 · Journal of Neuroscience Research
  32. TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms
    Megan M. Dykstra, Kaitlin Weskamp, Nicolás Gómez, Jacob Waksmacki, Elizabeth M.H. Tank, M. Rebecca Glineburg, Allison G. Snyder, Emile S. Pinarbasi, Michael E. Bekier, Xingli Li et al. · 2025 · Cell Reports
  33. Mitochondria at the crossroads: Quality control mechanisms in neuronal senescence and neurodegeneration
    Yifei Zheng, Jiahui Yang, Xuanyao Li, Linjie Qi, Zhuo Zheng, Jiming Kong, Guohui Zhang, Ying Guo · 2025 · Neurobiology of Disease
  34. Aberrant expression of TAR DNA binding protein-43 is associated with spermatogenic disorders in men
    Divya Saro Varghese, Uma Chandran, A. Soumya, Sathy M. Pillai, Krishnapillai Jayakrishnan, Prabhakara Poothi Reddi, Pradeep G. Kumar · 2014 · Reproduction Fertility and Development
  35. Assessing Computational Steps for CLIP-Seq Data Analysis
    Qi Liu, Xue Yun Zhong, Blair Madison, Anil K. Rustgi, Yu Shyr · 2015 · BioMed Research International
  36. Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle
    Ayan Banerjee, Brittany Lynn Phillips, Quidong Deng, Nicholas T. Seyfried, Grace K. Pavlath, Katherine E. Vest, Anita H. Corbett · 2019 · Journal of Biological Chemistry
  37. Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
    Katarzyna Gawęda-Walerych, Emilia Jadwiga Sitek, Ewa Narożańska, Emanuele Buratti · 2021 · Cells
  38. Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epigenetic modifications
    Miriam Pacetti, Laura De Conti, Luciano E. Marasco, Maurizio Romano, Mohammad Mamunur Rashid, Martina Nubiè, Francisco Ernesto Baralle, Marco Baralle · 2022 · Disease Models & Mechanisms
  39. Sequence Determinants of TDP-43 Ribonucleoprotein Condensate Formation and Axonal Transport in Neurons
    Sonali S. Vishal, Denethi Wijegunawardana, Muthu Raj Salaikumaran, Pallavi P. Gopal · 2022 · Frontiers in Cell and Developmental Biology
  40. The amyotrophic lateral sclerosis-linked protein TDP-43 regulates interleukin-6 cytokine production by human brain pericytes
    Scotter, Emma L., Cao, Maize C., Jansson, Deidre, Rustenhoven, Justin, Smyth, Leon C.D., Aalderink, Miranda C., Siemens, Andrew, Fan, Vicky, Wu, Jane, Mee, Edward W. et al. · 2022 · Molecular and Cellular Neuroscience
  41. RNA/DNA-binding protein TDP43 regulates DNA mismatch repair genes with implications for genome stability
    Vincent E. Provasek, Albino Bacolla, Suganya Rangaswamy, Manohar M. Kodavati, Joy Mitra, Issa Olakunle Yusuf, Vikas H. Malojirao, Velmarini Vasquez, Gavin Wayne Britz, Guo‐Min Li et al. · 2025 · Nucleic Acids Research
  42. Splicing does the two-step
    Heidi Cook‐Andersen, Miles Wilkinson · 2015 · Nature
  43. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate‐length CAG repeat expansions in Ataxin‐2 does not have 1 C 2‐positive polyglutamine inclusions
    J. Robin Highley, Alejandro Lorente-Pons, Johnathan Cooper‐Knock, Stephen B. Wharton, Paul G. Ince, Pamela J. Shaw, Jon D. Wood, Janine Kirby · 2015 · Neuropathology and Applied Neurobiology
  44. Reduced TDP-43 Expression Improves Neuronal Activities in a Drosophila Model of Perry Syndrome
    Yuka Hosaka, Tsuyoshi Inoshita, Kahori Shiba‐Fukushima, Changxu Cui, Taku Arano, Yuzuru Imai, Nobutaka Hattori · 2017 · EBioMedicine
  45. U6 snRNA expression prevents toxicity in TDP-43-knockdown cells
    Masao Yahara, Akira Kitamura, Masataka Kinjo · 2017 · PLoS ONE
  46. Drosophila as a Model to Gain Insight into the Role of lncRNAs in Neurological Disorders
    Lo Piccolo, Luca · 2018 · Advances in Experimental Medicine and Biology
  47. Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges
    Alina Brüge, Evgeni G. Ponimaskin, Josephine Labus · 2025 · Pharmacological Reviews
  48. Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction
    Caiwei Guo, Kuchuan Chen, Sarat C. Vatsavayai, Tetsuya Akiyama, Chang Liu, Yi Zeng, Odilia Sianto, Edith Yang, Juliane Bombosch, Rasheen Powell et al. · 2026 · Science Translational Medicine
  49. Characterization of the upstream and intron promoters of the gene encoding TAR DNA-binding protein
    Minami Hasegawa-Ogawa, Hirotaka James Okano · 2021 · Scientific Reports
  50. The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    O. H. Houghton, Sarah Mizielinska, Patricia Gómez‐Suaga · 2022 · Frontiers in Cell and Developmental Biology
  51. c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation
    Saebom Lee, Hye Guk Ryu, Sin Ho Kweon, Hyerynn Kim, Hyeonwoo Park, Kyung‐Ha Lee, Sang‐Min Jang, Chan Hyun Na, Sangjune Kim, Han Seok Ko · 2022 · Cells
  52. A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy
    Luca Lo Piccolo, Takanari Umegawachi, Ranchana Yeewa, Saranyapin Potikanond, Wutigri Nimlamool, Virapong Prachayasittikul, Yusuke Gotoh, Hideki Yoshida, Masamitsu Yamaguchi, Salinee Jantrapirom · 2023 · Neurotherapeutics
  53. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration
    Beibei Zhao, Catherine M. Cowan, Juliane A. Coutts, Darren Christy, Ananya Saraph, Shawn C. C. Hsueh, Stephen S. Plotkin, Ian R. Mackenzie, Johanne M Kaplan, Neil R. Cashman · 2023 · Acta Neuropathologica Communications
  54. Distribution of ubiquilin 2 and TDP ‐43 aggregates throughout the CNS in UBQLN2 p. T487I ‐linked amyotrophic lateral sclerosis and frontotemporal dementia
    Laura R. Nementzik, Kyrah M. Thumbadoo, Helen C. Murray, David Gordon, Shu Yang, Ian P. Blair, Clinton P. Turner, Richard L. M. Faull, Maurice A. Curtis, Catriona McLean et al. · 2023 · Brain Pathology
  55. Depletion of Mettl3 in cholinergic neurons causes adult-onset neuromuscular degeneration
    Georgia Dermentzaki, Mattia Furlan, Iris Tanaka, Tommaso Leonardi, Paola Rinchetti, Patricia M.S. Passos, Alliny Bastos, Yuna M. Ayala, Jacob H. Hanna, Serge Przedborski et al. · 2024 · Cell Reports
  56. The Glycoprotein Growth Factor Progranulin Promotes Carcinogenesis and has Potential Value in Anti-cancer Therapy
    Yonghua Zhang · 2012 · Journal of Carcinogenesis & Mutagenesis
  57. What Is the Role of Stathmin-2 in Axonal Biology and Degeneration?
    Eduardo Elias Benarroch · 2021 · Neurology
  58. Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models
    Cole D. Libner, Hannah E. Salapa, Catherine Hutchinson, Todd E Stang, Patricia A. Thibault, S. Austin Hammond, Michael C. Levin · 2022 · Neurobiology of Disease
  59. The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs
    Wim Robberecht, Caroline Eykens · 2015 · Advances in Genomics and Genetics
  60. Peroxiredoxin 1 post-transcriptionally regulates snoRNA expression
    Eun-Kyung Kim, Sun Young Lee, Yosup Kim, Sung‐Min Ahn, Ho Hee Jang · 2019 · Free Radical Biology and Medicine
  61. TDP-43 in ALS: Stay on Target…Almost There
    Ana Jovičić, Aaron D. Gitler · 2014 · Neuron
  62. Decoding Abnormal Splicing Code in Human Diseases
    Kinji Ohno · 2015 · Journal of Investigative Genomics
  63. Analysis of the substrate recognition state of TDP-43 to single-stranded DNA using fluorescence correlation spectroscopy
    Akira Kitamura, Ai Shibasaki, Kayo Takeda, Ryoji Suno, Masataka Kinjo · 2018 · Biochemistry and Biophysics Reports
  64. Dynamic duo – FMRP and TDP-43: Regulating common targets, causing different diseases
    Diana Ferro, Stephen Yao, Daniela C. Zarnescu · 2018 · Brain Research
  65. Decoding and recoding phase behavior of TDP43 reveals that phase separation is not required for splicing function
    Hermann Broder Schmidt, Ariana Barreau, Rajat Rohatgi · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer’s disease
    Stephen C. Gammie, Albee Messing, Mason A. Hill, Cynthia A. Kelm‐Nelson, Tracy L. Hagemann · 2024 · PLoS ONE
  67. Aberrant protein aggregation in amyotrophic lateral sclerosis
    Huaixiu Wang, Rong Zeng · 2024 · Journal of Neurology
  68. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis
    Mónica Zufiría, Oihane Pikatza‐Menoio, Maddi Garciandia-Arcelus, Xabier Bengoetxea, Andrés Jiménez-Zúñiga, Amaia Elicegui, María Levchuk, Olatz Arnold-García, Jon Ondaro, Pablo Iruzubieta et al. · 2024 · Acta Neuropathologica
  69. Hydrogen–Deuterium Exchange Mass Spectrometry Reveals Mechanistic Insights into RNA Oligonucleotide-Mediated Inhibition of TDP-43 Aggregation
    Thomas C. Minshull, Emily J. Byrd, Monika Olejnik, Antonio N. Calabrese · 2024 · Journal of the American Chemical Society
  70. CHMP2B promotes CHMP7 mediated nuclear pore complex injury in sporadic ALS
    Olivia Keeley, Emma Mendoza, Druv Menon, Alyssa N. Coyne · 2024 · Acta Neuropathologica Communications
  71. Relation of Alzheimer's disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI)
    Anna Lavrova, Nha Trang Thu Pham, Robert I. Reid, Bradley F. Boeve, David S. Knopman, Ronald Carl Petersen, Aivi T. Nguyen, Robert Ross Reichard, Dennis W. Dickson, Clifford R. Jack et al. · 2025 · Neurobiology of Aging
  72. Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination
    Zodwa Dlamini, Kgomotso Mathabe, Llewellyn C. Padayachy, Rahaba Makgotso Marima, George Evangelou, Konstantinos Nikolaos Syrigos, Arianna Bianchi, Georgios Lolas, Rodney Hull · 2021 · Cancers
  73. Motoneuron Disease
    Michael Sendtner · 2014 · Handbook of experimental pharmacology
  74. Pum2 and TDP-43 refine area-specific cytoarchitecture post-mitotically and modulate translation of Sox5, Bcl11b, and Rorb mRNAs in developing mouse neocortex
    Kawssar Harb, Melanie Richter, Nagammal Neelagandan, Elia Magrinelli, Hend Harfoush, Katrin Kuechler, Melad Henis, Irm Hermanns-Borgmeyer, Froylán Calderón de Anda, Kent E. Duncan · 2022 · eLife
  75. Cryptic inclusions UNCover losses driving neurodegeneration
    Adekunle T. Bademosi, Adam K. Walker · 2022 · Trends in Genetics
  76. Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 0 (ICP0) Targets of Ubiquitination during Productive Infection of Primary Adult Sensory Neurons
    Telvin L. Harrell, David J. Davido, Andrea S. Bertke · 2023 · International Journal of Molecular Sciences
  77. Single Versus Repetitive Traumatic Brain Injury: Current Knowledge on the Chronic Outcomes, Neuropathology and the Role of TDP-43 Proteinopathy
    Tamara Janković, Kristina Pilipović · 2023 · Experimental Neurobiology
  78. Tight expression regulation of senataxin, linked to motor neuron disease and ataxia, is required to avert cell-cycle block and nucleolus disassembly
    Craig L. Bennett, Bryce L. Sopher, Albert R. La Spada · 2020 · Heliyon
  79. Downstream Effects of Mutations in SOD1 and TARDBP Converge on Gene Expression Impairment in Patient-Derived Motor Neurons
    Banaja P. Dash, Axel Freischmidt, Jochen Hans Weishaupt, Andreas Hermann · 2022 · International Journal of Molecular Sciences
  80. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies
    Kana Mitsuhashi, Daisuke Ito, Kyoko Mashima, Munenori Oyama, Shinichi Takahashi, Norihiro Suzuki · 2017 · Scientific Reports
  81. Early alterations of RNA metabolism and splicing from adult corticospinal neurons in an ALS mouse model
    Christine Marques, Mathieu Fischer, Céline Keime, Thibaut Burg, Aurore Brunet, Jelena Scekic‐Zahirovic, Caroline Rouaux · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  82. ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation
    Baggio Evangelista, Joey V. Ragusa, Kyle Pellegrino, Yijia Wu, Ivana Yoseli Quiroga, Shannon R. Cahalan, Omeed K Arooji, Jillann A. Madren, Sally Schroeter, Joe Cozzarin et al. · 2025 · iScience
  83. TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target
    Yara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, Rudolf C. Hergesheimer, Patrick Vourc’h, Philippe Corcia, Débora Lanznaster, Hélène Blasco · 2022 · Expert Opinion on Therapeutic Targets
  84. Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1
    Edward Pokrishevsky, Michèle G. DuVal, Luke McAlary, Sarah Louadi, Silvia Pozzi, Andrei Yu. Roman, Steven Samuel Plotkin, Anke A. Dijkstra, Jean‐Pierre Julien, W. Ted Allison et al. · 2024 · Journal of Biological Chemistry
  85. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion
    Evan Udine, Mariely DeJesus‐Hernandez, Shulan Tian, Sofia Pereira das Neves, Richard Crook, NiCole A. Finch, Matthew Baker, Cyril P. Pottier, Neill R. Graff‐Radford, Bradley F. Boeve et al. · 2024 · Acta Neuropathologica
  86. Identifying FUS amyotrophic lateral sclerosis disease signatures in patient dermal fibroblasts
    Karl Kumbier, Maike A. Roth, Zizheng Li, Julia R. Lazzari-Dean, Christopher Waters, Sabrina Hammerlindl, Capria Rinaldi, Ping Huang, Vlad A. Korben, Hemali P. Phatnani et al. · 2024 · Developmental Cell
  87. Abnormal Splicing Events due to Loss of Nuclear Function of TDP-43: Pathophysiology and Perspectives
    Yuka Mitsuhashi Koike · 2024 · JMA Journal
  88. Genetic and Mechanistic Insights Inform Amyotrophic Lateral Sclerosis Treatment and Symptomatic Management: Current and Emerging Therapeutics and Clinical Trial Design Considerations
    Suzanne Quigley, Kellen H. Quigg, Stephen A. Goutman · 2025 · CNS Drugs
  89. Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish
    Doris Lou Demy, Maria‐Letizia Campanari, Raphael Munoz‐Ruiz, Heather D. Durham, Benoît J. Gentil, Edor Kabashi · 2020 · Cells
  90. Thermodynamic modulation of folding and aggregation energy landscape by DNA binding of functional domains of TDP-43
    Divya Patni, Santosh Kumar Jha · 2023 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  91. From the disruption of RNA metabolism to the targeting of RNA ‐binding proteins: The case of polyglutamine spinocerebellar ataxias
    Tiago Moreira‐Gomes, Clévio Nóbrega · 2023 · Journal of Neurochemistry
  92. Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis
    Xiaoyan Li, Richard Bedlack · 2024 · Expert Opinion on Emerging Drugs
  93. Initial gene vector dosing for studying symptomatology of amyotrophic lateral sclerosis in non‐human primates
    Kasey L. Jackson, Robert D. Dayton, Jeanne M. Fisher‐Perkins, Peter J. Didier, Kate C. Baker, Maria B. Weimer, Amparo Gutierrez, Cooper D. Cain, James Michael Mathis, Michael A. Gitcho et al. · 2015 · Journal of Medical Primatology
  94. Sortilin-related receptor CNS expressed 2 (SorCS2) is localized to Bunina bodies in amyotrophic lateral sclerosis
    Fumiaki Mori, Yasuo Miki, Kunikazu Tanji, Akiyoshi Kakita, Hitoshi Takahashi, Jun Utsumi, Hidenao Sasaki, Koichi Wakabayashi · 2015 · Neuroscience Letters
  95. TDP-43 overexpression impairs presynaptic integrity
    CharbelE-H Moussa, Lanier Heyburn · 2016 · Neural Regeneration Research
  96. Molecular Mechanisms of Amyotrophic Lateral Sclerosis
    Mahlon A. Collins, Robert P. Bowser · 2017 · Elsevier eBooks
  97. Drosophila CG3303 is an essential endoribonuclease linked to TDP-43-mediated neurodegeneration
    Pietro Laneve, Lucia Piacentini, Assunta Maria Casale, Davide Capauto, Ubaldo Gioia, Ugo Cappucci, Valerio Di Carlo, Irene Bozzoni, Patrizio Di Micco, Veronica Morea et al. · 2017 · Scientific Reports
  98. Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Zongbing Hao, Rui Wang, Haigang Ren, Guanghui Wang · 2020 · Neuroscience Bulletin
  99. Unannotated splicing regulatory elements in deep intron space
    John G. Conboy · 2021 · Wiley Interdisciplinary Reviews - RNA
  100. <Original Article>TDP-43 in the skin of amyotrophic lateral sclerosis patients.
    Keisuke Abe, Takuya Ohkubo, Takanori Yokota · 2017 · PubMed